{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:00:33Z","timestamp":1792807233367,"version":"4.5.0"},"reference-count":30,"publisher":"CMA Impact Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.9778\/cmajo.20210257","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T12:36:57Z","timestamp":1664282217000},"page":"E841-E847","source":"Crossref","is-referenced-by-count":8,"title":["Chronic diseases and compliance with provincial guidelines for outpatient antibiotic prescription in cases of otitis media and respiratory infections: a population-based study of linked data in Quebec, Canada, 2010\u20132017"],"prefix":"10.9778","volume":"10","author":[{"given":"\u00c9lise","family":"Fortin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Deceuninck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Irace-Cima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Magali-Ufitinema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"2022092705201238000_10.3.E841.1","unstructured":"(2015) Plan d\u2019action f\u00e9d\u00e9ral sur la r\u00e9sistance et le recours aux antimicrobiens au Canada: prolongement du cadre d\u2019action f\u00e9d\u00e9ral (Agence de sant\u00e9 publique du Canada, Ottawa) Available: https:\/\/www.deslibris.ca\/ID\/10046895 . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.2","unstructured":"(2016) Global action plan on antimicrobial resistance (World Health Organization, Geneva) Availablehttps:\/\/www.who.int\/publications\/i\/item\/9789241509763 . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.3","unstructured":"The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada (2019) When antibiotics fail (Council of Canadian Academies), Available: https:\/\/canadacommons.ca\/artifacts\/1188359\/when-antibiotics-fail\/1741482\/ . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.4","unstructured":"Department of Health; Department of Agriculture, Water and the Environment (2020) Australia\u2019s National Antimicrobial Resistance Strategy: 2020 and beyond [report] (Australian Government, Canberra (AU)) Available: https:\/\/www.amr.gov.au\/resources\/australias-national-antimicrobial-resistance-strategy-2020-and-beyond , pp 1\u201318. accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.5","unstructured":"Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) (Centres for Disease Control and Prevention, Atlanta) reviewed 2021 Mar. 1. Available: https:\/\/www.cdc.gov\/drugresistance\/tatfar\/index.html . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.6","unstructured":"(2020) 10 global health issues to track in 2021 (World Health Organization, Geneva) Availablehttps:\/\/www.who.int\/news-room\/spotlight\/10-global-health-issues-to-track-in-2021 . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.7","unstructured":"Canadian Antimicrobial Resistance Surveillance System Report: update 2020 (Public Health Agency of Canada, Ottawa) modified 2020 July 9, Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/drugs-health-products\/canadian-antimicrobial-resistance-surveillance-system-2020-report.html , pp 1\u2013108. accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.8","unstructured":"(2011) Circulaire 2011-021, Mise en oeuvre d\u2019un programme de surveillance de l\u2019usage des antibiotiques en \u00e9tablissement de sant\u00e9 (Minist\u00e8re de la Sant\u00e9 et des Services sociaux, Qu\u00e9bec)."},{"key":"2022092705201238000_10.3.E841.9","unstructured":"Conseil du m\u00e9dicament (2008) Cadre de r\u00e9f\u00e9rence relatif \u00e0 l\u2019usage optimal des anti-infectieux et au suivi de l\u2019utilisation de ces m\u00e9dicaments en milieu hospitalier (Gouvernement du Qu\u00e9bec, Qu\u00e9bec), pp 1\u201380, Available: https:\/\/numerique.banq.qc.ca\/patrimoine\/details\/52327\/1565777 . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.10","unstructured":"(2021) Guides d\u2019usage optimal (Institut national d\u2019excellence en sant\u00e9 et en services sociaux, Qu\u00e9bec) Available: https:\/\/www.inesss.qc.ca\/outils-cliniques\/outils-cliniques\/outils-par-types\/guides-dusage-optimal.html . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.11","unstructured":"Antimicrobial consumption database (ESAC-Net) (European Centre for Disease Prevention and Control, Solna (Sweden)) Available: https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-consumption\/surveillance-and-disease-data\/database . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.12","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20210258"},{"key":"2022092705201238000_10.3.E841.13","unstructured":"ATC\/DDD Index 2017 (WHO Collaborating Centre for Drug Statistics Methodology, Oslo (Norway)) updated 2021 Dec. 14. Available: https:\/\/www.whocc.no\/atc_ddd_index\/ . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.24095\/hpcdp.34.4.06","article-title":"Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach","volume":"34","author":"Blais","year":"2014","journal-title":"Chronic Dis Inj Can"},{"key":"2022092705201238000_10.3.E841.15","doi-asserted-by":"crossref","unstructured":"Talbot D M\u00e9sidor M Chiu Y (Mar 30, 2022) ArXiv, An alternative perspective on the robust Poisson model for estimating risk or prevalence ratios. Available: https:\/\/arxiv.org\/abs\/2112.00547 . accessed 2022 June 14.","DOI":"10.1097\/EDE.0000000000001544"},{"key":"2022092705201238000_10.3.E841.16","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1093\/jac\/dkz345","article-title":"Antibiotic choice in UK general practice: rates and drivers of potentially inappropriate antibiotic prescribing","volume":"74","author":"Nowakowska","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022092705201238000_10.3.E841.17","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1093\/jac\/dkz221","article-title":"Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients","volume":"74","author":"Wang","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022092705201238000_10.3.E841.18","unstructured":"Lefebvre F (2021) Impact des maladies chroniques sur l\u2019adh\u00e9sion aux recommandations cliniques dans le traitement des infections urinaires [dissertation]. Available: https:\/\/corpus.ulaval.ca\/jspui\/handle\/20.500.11794\/69045?locale=fr (Universit\u00e9 Laval, Qu\u00e9bec), pp 1\u201370. accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.19","unstructured":"(2019) Overweight and obese adults, 2018 [health fact sheets] (Statistics Canada, Ottawa) Availablehttps:\/\/www150.statcan.gc.ca\/n1\/pub\/82-625-x\/2019001\/article\/00005-eng.htm . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.20","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318180fe62"},{"key":"2022092705201238000_10.3.E841.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3418"},{"key":"2022092705201238000_10.3.E841.22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis629"},{"key":"2022092705201238000_10.3.E841.23","doi-asserted-by":"publisher","DOI":"10.1086\/513768"},{"key":"2022092705201238000_10.3.E841.24","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx500"},{"key":"2022092705201238000_10.3.E841.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4151"},{"key":"2022092705201238000_10.3.E841.26","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.070151"},{"key":"2022092705201238000_10.3.E841.27","unstructured":"Know the eligibility conditions for the public plan (R\u00e9gie de l\u2019assurance maladie, Qu\u00e9bec) Available: https:\/\/www.ramq.gouv.qc.ca\/en\/citizens\/prescription-drug-insurance\/know-eligibility-conditions-public-plan . accessed 2022 June 14."},{"key":"2022092705201238000_10.3.E841.28","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20190175"},{"key":"2022092705201238000_10.3.E841.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2008.00873.x"},{"key":"2022092705201238000_10.3.E841.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026396"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20210257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T12:39:28Z","timestamp":1664282368000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20210257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,27]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.9778\/cmajo.20210257"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20210257","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}